EFT Holdings, Inc. - FORM 10-Q - EX-32.1 - November 16, 2009

Attached files

file filename
10-Q - EFT Holdings, Inc.v166685_10q.htm
EX-32.2 - EFT Holdings, Inc.v166685_ex32-2.htm
EX-31.2 - EFT Holdings, Inc.v166685_ex31-2.htm
EX-31.1 - EFT Holdings, Inc.v166685_ex31-1.htm
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the accompanying Quarterly Report on Form 10-Q of EFT BioTech Holdings, Inc. (the “Company”) for the quarter ending September 30, 2009 (the “Report”), I, Sharon Tang, Chief Financial Officer of the Company hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:
 
1.
Such Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2.
The information contained in such Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

       
Dated: November 16, 2009
 
 /s/ JACK JIE QIN  
   
Jack Jie Qin
  
   
Chief Executive Officer, President and Chairman
(Principal Executive Officer)
  
 
 
 
 

EFT Holdings, Inc. Reports